Nifedipine: individual responses and concentration-effect relationships

Area of Science:

• Pharmacokinetics and Pharmacodynamics
• Cardiovascular Medicine
• Clinical Pharmacology

Background:

• Significant intersubject variability exists in the antihypertensive response to nifedipine.
• A clear nifedipine concentration-effect relationship has not been established in essential hypertension.
• Understanding individual responsiveness is crucial for optimizing nifedipine therapy.

Purpose of the Study:

• To characterize the antihypertensive response to nifedipine by integrating kinetic and dynamic data.
• To establish individual nifedipine concentration-effect relationships in patients with essential hypertension.
• To assess the consistency of nifedipine responsiveness over time (first dose vs. chronic treatment).

Main Methods:

• A study involving 14 subjects with essential hypertension.
• Evaluation of placebo, first-dose, and chronic (1 and 6 weeks) nifedipine treatment.
• Utilized an integrated kinetic-dynamic model to calculate individual subject responsiveness (fall in blood pressure per unit drug concentration).

Main Results:

• Nifedipine concentrations strongly correlated with systolic blood pressure reduction in individual subjects.
• Mean responsiveness remained consistent across different treatment durations: -0.48 mm Hg/ng/ml (first dose), -0.45 mm Hg/ng/ml (1 week), and -0.49 mm Hg/ng/ml (6 weeks).
• First-dose responsiveness significantly correlated with responsiveness at 1 and 6 weeks, and with pretreatment blood pressure.

Conclusions:

• Integrated kinetic and dynamic modeling effectively characterizes the antihypertensive response to nifedipine.
• Individual nifedipine concentration-effect relationships can be identified, supporting personalized medicine approaches.
• Early responsiveness predicts later therapeutic response, suggesting potential for early treatment optimization.